Zhe-Sheng Chen

The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer

Zhe-Sheng Chen, Chaohua Hu, Zhuoxun Wu, 2020, Molecular Cancer.

Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer

Jiali Yang, Huaizhi Wang, Chao-Yun Cai, 2022, Molecular cancer.

GLUL stabilizes N-Cadherin by antagonizing β-Catenin to inhibit the progresses of gastric cancer

Z. Shi, Meiwan Chen, Zhe-Sheng Chen, 2023, Acta pharmaceutica Sinica. B.

NAT10 Promotes Prostate Cancer Growth and Metastasis by Acetylating mRNAs of HMGA1 and KRT8

Chong Wang, Yu-zhong Yu, Tao Xie, 2024, Advanced science.

SETD4 inhibits prostate cancer development by promoting H3K27me3-mediated NUPR1 transcriptional repression and cell cycle arrest.

Tao Wang, Chong Wang, Yu-zhong Yu, 2023, Cancer letters.